Literature DB >> 21872630

Estimated acceptance of HPV vaccination among Italian women aged 18-26 years.

Cristina Giambi1, Serena Donati, Silvia Declich, Stefania Salmaso, Marta Luisa Ciofi Degli Atti, Maria Pia Alibrandi, Silvia Brezzi, Francesca Carozzi, Natalina Collina, Daniela Franchi, Amedeo Lattanzi, Margherita Meda, Maria Carmela Minna, Roberto Nannini, Isabella Scherillo, Antonino Bella.   

Abstract

In Italy vaccination against human papillomavirus (HPV) was introduced in the national immunization programme in 2007; the primary target for this vaccination is 11-year-old females, whereas vaccination for older age groups is still a matter of debate. This project was carried out in the period 2007-2009 to estimate the acceptance rate among 18-26-year-old, to whom free-of-charge vaccination was actively offered. Socio-demographic factors associated with acceptance were also investigated. A sample of 1159 women was randomly selected from resident population lists of 10 Local Health Units in 6 of Italy's 21 Regions; 1032 women were deemed eligible for the study. Of the eligible women, 580 received at least one vaccine dose for an acceptance rate of 56.2% and 542 received all three vaccine doses (52.6%). The acceptance rate was significantly higher for: residents of northern and central Italy (OR(adj)=2.22, 95%CI 1.64-3.01 and OR(adj)=1.77, 95%CI, 1.20-2.61 respectively), compared to southern Italy; women with a high educational level (OR(adj)=1.41; 95%CI: 1.02-1.93); and students (OR(adj)=1.64; 95%CI: 1.13-2.37). The low immunization rate highlights the difficulties of reaching young adult women, although the current coverage rates observed in the primary target population of HPV vaccination campaign (64%) emphasize that achieving high coverage rates is challenging also in younger age groups. Our results suggest that it would be premature to extend the active free-of-charge offer of HPV vaccination to older women and that efforts should be focused on the priority target, considering that the objective of 95% coverage established for this age group is still far from being attained.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21872630     DOI: 10.1016/j.vaccine.2011.08.079

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  9 in total

1.  A cross-sectional study to estimate high-risk human papillomavirus prevalence and type distribution in Italian women aged 18-26 years.

Authors:  Cristina Giambi; Serena Donati; Francesca Carozzi; Stefania Salmaso; Silvia Declich; Marta L Ciofi degli Atti; Guglielmo Ronco; Maria P Alibrandi; Silvia Brezzi; Natalina Collina; Daniela Franchi; Amedeo Lattanzi; Maria C Minna; Roberto Nannini; Elena Barretta; Elena Burroni; Anna Gillio-Tos; Vincenzo Macallini; Paola Pierotti; Antonino Bella
Journal:  BMC Infect Dis       Date:  2013-02-07       Impact factor: 3.090

2.  Parental attitudes towards male human papillomavirus vaccination: a pan-European cross-sectional survey.

Authors:  Gitte Lee Mortensen; Marjorie Adam; Laïla Idtaleb
Journal:  BMC Public Health       Date:  2015-07-08       Impact factor: 3.295

3.  Multicenter study of human papillomavirus and the human papillomavirus vaccine: knowledge and attitudes among people of African descent.

Authors:  Elizabeth Blackman; Natalie Thurman; Darron Halliday; Raleigh Butler; Dorita Francis; Madeline Joseph; Jahzreel Thompson; Aletha Akers; Cecile Andraos-Selim; Cornelius Bondzi; Emanuela Taioli; Kourtney L Hagan; Erin A Jones; Jade Jones; Cierra M Moss; Ar'Lena C Smith; Kimlin Tam Ashing; Camille C Ragin
Journal:  Infect Dis Obstet Gynecol       Date:  2013-07-16

Review 4.  Viral and cellular biomarkers in the diagnosis of cervical intraepithelial neoplasia and cancer.

Authors:  Maria Lina Tornesello; Luigi Buonaguro; Paolo Giorgi-Rossi; Franco M Buonaguro
Journal:  Biomed Res Int       Date:  2013-12-09       Impact factor: 3.411

5.  Sexual behavior and factors associated with young age at first intercourse and HPV vaccine uptake among young women in Germany: implications for HPV vaccination policies.

Authors:  Cornelius Remschmidt; Michaela Fesenfeld; Andreas M Kaufmann; Yvonne Deleré
Journal:  BMC Public Health       Date:  2014-12-05       Impact factor: 3.295

6.  HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe.

Authors:  Emilie Karafillakis; Clarissa Simas; Caitlin Jarrett; Pierre Verger; Patrick Peretti-Watel; Fadia Dib; Stefania De Angelis; Judit Takacs; Karam Adel Ali; Lucia Pastore Celentano; Heidi Larson
Journal:  Hum Vaccin Immunother       Date:  2019-02-20       Impact factor: 3.452

Review 7.  Determinants in the Uptake of the Human Papillomavirus Vaccine: A Systematic Review Based on European Studies.

Authors:  Victoria Fernández de Casadevante; Julita Gil Cuesta; Lourdes Cantarero-Arévalo
Journal:  Front Oncol       Date:  2015-06-24       Impact factor: 6.244

8.  Vaccine knowledge in students in Paris, France, and surrounding regions.

Authors:  Guillaume Mellon; Laurent Rigal; Henri Partouche; Olivier Aoun; Philippe Jaury; Nathalie Joannard; Jean Paul Guthmann; Delphine Cochereau; Eric Caumes; Francois Bricaire; Dominique Salmon-Céron
Journal:  Can J Infect Dis Med Microbiol       Date:  2014-05       Impact factor: 2.471

9.  Exploring variation in human papillomavirus vaccination uptake in Switzerland: a multilevel spatial analysis of a national vaccination coverage survey.

Authors:  Maurane Riesen; Garyfallos Konstantinoudis; Ben D Spycher; Christian L Althaus; Phung Lang; Nicola Low; Christoph Hatz; Mirjam Maeusezahl; Anne Spaar; Marc Bühlmann
Journal:  BMJ Open       Date:  2018-05-17       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.